Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics

  • John R. Dimitry
  • Justin A. EzekowitzEmail author


In recent years, the incidence and prevalence of heart failure (HF) has risen to epidemic proportions and has a direct correlation with aging; HF affects <1 % of adults under 50 years of age, but in patients over 80, the prevalence exceeds 10 %. Optimizing heart failure therapy in clinics under the guidance of multidisciplinary management teams has been shown to reduce readmission rates and mortality. Several contemporary randomized trials have shown up to 50 % fewer hospital readmissions with multidisciplinary HF intervention teams versus usual care whoever in the aging population poses unique challenges in management. A multidisciplinary approach and a thorough understanding of cardiology, geriatrics, and internal medicine are necessary. An important consideration often overlooked by healthcare professionals is that heart failure interventions may further contribute to patient frailty and complicate management. In this chapter we discuss the options and considerations for managing elderly patients with heart failure.


Heart Failure Cardiac Resynchronization Therapy Heart Failure Hospitalization Comorbid Illness Heart Failure Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hauptman PJ, Rich MW, Heidenreich PA, Chin J, Cummings N, Dunlap ME, et al. The heart failure clinic: a consensus statement of the Heart Failure Society of America. J Card Fail. 2008;14:801–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Ezekowitz JA, Kaul P, Bakal JA, Quan H, McAlister FA. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail. 2011;13(2):142–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Arnold JMO, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol. 2006;22:23–45.PubMedCrossRefGoogle Scholar
  4. 4.
    Johansen H, Strauss B, Arnold JMO, Moe G, Liu P. On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol. 2003;19(4):430–5.PubMedGoogle Scholar
  5. 5.
    Ezekowitz JA, Bakal JA, Kaul P, Westerhout CM, Armstrong PW. Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail. 2008;10(3):308–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Rich MW. Heart failure in the elderly: strategies to optimize outpatient control and reduce hospitalizations. Am J Geriatr Cardiol. 2003;12(1):19–24.PubMedCrossRefGoogle Scholar
  7. 7.
    McAlister FA, Teo KK, Taher M, Montague TJ, Humen D, Cheung L, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999;138(1 Pt 1):87–94.PubMedCrossRefGoogle Scholar
  8. 8.
    McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110(5):378–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Howlett JG, McKelvie RS, Costigan J, Ducharme A, Estrella-Holder E, Ezekowitz JA, et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol. 2010;26:185–202.PubMedCrossRefGoogle Scholar
  10. 10.
    McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction. JAMA. 2007;297(22):2502–14.PubMedCrossRefGoogle Scholar
  11. 11.
    Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, et al. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147(4):251–62.PubMedCrossRefGoogle Scholar
  12. 12.
    Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154(6):401–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med. 1995;155(10):1060–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Tresch DD. The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc. 1997;45(9):1128–33.PubMedGoogle Scholar
  15. 15.
    Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355(5):488–98.Google Scholar
  16. 16.
    Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, Hildebrandt PR. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice. Int J Clin Pract. 2007;61(9):1481–91.PubMedCrossRefGoogle Scholar
  17. 17.
    von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129–33.CrossRefGoogle Scholar
  18. 18.
    Oreopoulos A, Kalantar-Zadeh K, McAlister FA, Ezekowitz JA, Fonarow GC, Johnson JA, et al. Comparison of direct body composition assessment methods in patients with chronic heart failure. J Card Fail. 2010;16(11):867–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc. 1998;46(11):1343–8.PubMedGoogle Scholar
  20. 20.
    Vogels RLC, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, et al. Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc. 2007;55(11):1764–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166(9):1003–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1–194.PubMedCrossRefGoogle Scholar
  23. 23.
    Authors/Task Force Members, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787–847.PubMedCrossRefGoogle Scholar
  24. 24.
    Tjam EY, Heckman GA, Smith S, Arai B, Hirdes J, Poss J, et al. Predicting heart failure mortality in frail seniors: comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0. Int J Cardiol. 2012;155(1):75–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRefGoogle Scholar
  26. 26.
    McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella-Holder E, et al. The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol. 2011;27(3):319–38.PubMedCrossRefGoogle Scholar
  27. 27.
    Arnold JMO, Howlett JG, Dorian P, Ducharme A, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol. 2007;23:21–45.PubMedCrossRefGoogle Scholar
  28. 28.
    Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PWF, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90(3):254–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett Jr JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40(5):976–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Felker GM, Hasselblad V, Hernandez AF, O’Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J. 2009;158(3):422–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, et al. BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383–92.PubMedCrossRefGoogle Scholar
  32. 32.
    Maeder MT, Rickli H, Pfisterer ME, Muzzarelli S, Ammann P, Fehr T, et al. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J. 2012;163(3):407–14. 414.e1.PubMedCrossRefGoogle Scholar
  33. 33.
    Tonkin AL, Wing LM. Effects of age and isolated systolic hypertension on cardiovascular reflexes. J Hypertens. 1994;12(9):1083–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Cléroux J, Giannattasio C, Grassi G, Seravalle G, Sampieri L, Cuspidi C, et al. Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans. J Hypertens Suppl. 1988;6(4):S141–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials. JAMA. 1995;273(18):1450–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Foody JM, Farrell MH, Krumholz HM. beta-Blocker therapy in heart failure: scientific review. JAMA. 2002;287(7):883–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Muzzarelli S, Maeder MT, Toggweiler S, Rickli H, Nietlispach F, Julius B, et al. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy. Am J Cardiol. 2012;109(5):693–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Zannad F, McMurray JJV, Krum H, Van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Muzzarelli S, Tobler D, Leibundgut G, Schindler R, Buser P, Pfisterer ME, et al. Detection of intake of nonsteroidal anti-inflammatory drugs in elderly patients with heart failure. How to ask the patient? Swiss Med Wkly. 2009;139(33–34):481–5.PubMedGoogle Scholar
  41. 41.
    Healey JS, Hallstrom AP, Kuck K-H, Nair G, Schron EP, Roberts RS, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J. 2007;28(14):1746–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49(25):2408–15.PubMedCrossRefGoogle Scholar
  43. 43.
    Cleland J, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRefGoogle Scholar
  44. 44.
    Arcand J, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, et al. A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr. 2011;93(2):332–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Arcand JAL, Brazel S, Joliffe C, Choleva M, Berkoff F, Allard JP, et al. Education by a dietitian in patients with heart failure results in improved adherence with a sodium-restricted diet: a randomized trial. Am Heart J. 2005;150(4):716.PubMedCrossRefGoogle Scholar
  46. 46.
    Brunner-La Rocca HP, Rickenbacher P, Muzzarelli S, Schindler R, Maeder MT, Jeker U, et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J. 2012;33(6):752–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Thai V, Ezekowitz JA, Cujec B. A call to action: cardiac palliative care. J Palliat Med. 2009;12(4):289–90.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Cardiology, Department of MedicineUniversity of Alberta and Mazankowski Alberta Heart InstituteEdmontonCanada
  2. 2.Division of Cardiology, Department of MedicineUniversity of AlbertaEdmontonCanada

Personalised recommendations